Wagner F. Gattaz - Concepedia

Author

Wagner F. Gattaz

Also Known As

A Hillert', GATTAZ, WAGNER F., Gattaz, Wagner, Gattaz, Wagner F., Gattaz, Wagner Farid, Moacyr Alexandro Rosa, V Arolt, W F Gattaz, W GATTAZ, W Gattaz

557

Publications

21.2K

Citations

H-Index

196

Concepts

All Affiliations

Universidade de São Paulo Central Institute of Mental Health Universidade Federal de Minas Gerais Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo National Institute of Mental Health

About

Wagner F. Gattaz is an author at Universidade de São Paulo specializing in medicine, neuroscience, and psychiatry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	54	153	8.5K
2	Health Sciences	5	5	440
3	Natural Sciences	3	3	114
4	Education	2	2	62
5	Arts	1	1	18

Wagner F. Gattaz

240

Publications

14.9K

Citations

H-Index

Page 1

	Year	Citations
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects Alkomiet Hasan, Peter Falkai, Thomas Wobrock, The World Journal of Biological Psychiatry	2012	409
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression André R. Brunoni, Adriano H. Moffa, Bernardo Sampaio-Júnior, New England Journal of Medicine	2017	398
Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial Orestes Vicente Forlenza, Breno S. Diniz, Márcia Radanovic, The British Journal of Psychiatry	2011	380
Mental Disorders in Megacities: Findings from the São Paulo Megacity Mental Health Survey, Brazil Laura Helena Andrade, Yuan‐Pang Wang, Solange Andreoni, PLoS ONE	2012	368
Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder Paula Villela Nunes, Orestes Vicente Forlenza, Wagner F. Gattaz The British Journal of Psychiatry	2007	365
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Long-term treatment of schizophrenia Peter Falkai, Thomas Wobrock, Jeffrey A. Lieberman, The World Journal of Biological Psychiatry NeuropsychologyPsychotropic MedicationElectroconvulsive TherapyPsychopharmacologyPharmacotherapy	2006	331
Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: A double-blind placebo-controlled study Demétrio Ortega Rumi, Wagner F. Gattaz, Sergio P. Rigonatti, Biological Psychiatry Double-blind Placebo-controlled StudyPsychiatryMood SymptomMedicineSubcortical Ischemic Depression	2005	227
The Epidemiology of Early Schizophrenia Heinz Häfner, Kathrin Maurer, W. Löffler, The British Journal of Psychiatry	1994	218
Increased plasma phospholipase-A2 activity in schizophrenic patients: Reduction after neuroleptic therapy Wagner F. Gattaz, Manfred Köllisch, Tom Thurén, Biological Psychiatry Schizophrenic PatientsPlasma Phospholipase-a2 ActivityMedicinePsychotropic MedicationPsychopharmacology	1987	214
Increased Serum IL-1β Level in Alzheimer’s Disease and Mild Cognitive Impairment Orestes Vicente Forlenza, Breno S. Diniz, Leda Leme Talib, Dementia and Geriatric Cognitive Disorders	2009	210

Page 1